J&J Beats on Q3 Earnings, Raises Sales View but Cuts EPS Guidance
J&J(JNJ) ZACKS·2024-10-15 16:30Johnson & Johnson’s (JNJ) third-quarter 2024 earnings came in at $2.42 per share, which beat the Zacks Consensus Estimate of $2.22. Earnings declined 9% from the year-ago period.Adjusted earnings exclude a one-time special charge, including which, reported earnings were $1.11 per share, down 34.3% year over year.Sales of this drug and medical devices giant came in at $22.47 billion, which beat the Zacks Consensus Estimate of $22.19 billion. Sales rose 5.2% from the year-ago quarter, reflecting an operationa ...